The DOI matches its Crossref record; 179 of the 179 references it cites were found in a registry or an index.
Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases
Open accessAbstract
Apoptosis is crucial for the normal development of the nervous system, whereas neurons in the adult CNS are relatively resistant to this form of cell death. However, under pathological conditions, upregulation of death receptor family ligands, such as tumour necrosis factor (TNF), can sensitize cells in the CNS to apoptosis and a form of regulated necrotic cell death known as necroptosis that is mediated by receptor-interacting protein kinase 1 (RIPK1), RIPK3 and mixed lineage kinase domain-like protein (MLKL). Necroptosis promotes further cell death and neuroinflammation in the pathogenesis of several neurodegenerative diseases, including multiple sclerosis, amyotrophic lateral sclerosis, Parkinson disease and Alzheimer disease. In this Review, we outline the evidence implicating necroptosis in these neurological diseases and suggest that targeting RIPK1 might help to inhibit multiple cell death pathways and ameliorate neuroinflammation. Necroptosis is a form of cell death mediated by receptor-interacting protein kinase 1 (RIPK1), and is observed in several CNS disorders. Here, Yuan, Amin and Ofengeim give an overview of necroptosis in the CNS and explain its relationship with inflammation in CNS disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased activation of TNF/TNFR1 signalling following chronic activation of microglia can give rise to TNF-mediated necroptotic neuronal cell death, 160 which represents a possible therapeutic target in Parkinson's disease.161”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [161]
Experimental — accuracy not yet measuredIn the citing paper
“Yet, several genes that have been implicated in neuroinflammation38 (such as RIPK1) were seen specifically in microglial states associated with COVID-19.”
From Dysregulation of brain and choroid plexus cell types in severe COVID-19 (2021) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glutamate neurotoxicity and diseases of the nervous system
Choi, D. W. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 8,188
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875
Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
Degterev, A., Huang, Z., Boyce, M., Li, Y., Jagtap, P., Mizushima, N., Cuny, G. D., Mitchison, T. J., Moskowitz, M. A., & Yuan, J. (2005) · Nature Chemical Biology · doi:10.1038/nchembio711 · Cited by 3,068
Self-citationInduction of TNF receptor I-mediated apoptosis via two sequential signaling complexes
Micheau, O., & Tschopp, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00521-x · Cited by 2,738
Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase
Sun, L., Wang, H., Wang, Z., He, S., Chen, S., Liao, D., Wang, L., Yan, J., Liu, W., Lei, X., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.031 · Cited by 2,698
Ji, Y. (1993) · Cell · doi:10.1016/0092-8674(93)90485-9 · Cited by 2,497
Cho, Y., Challa, S., Moquin, D., Genga, R., Ray, T. D., Guildford, M., & Chan, F. K.-M. (2009) · Cell · doi:10.1016/j.cell.2009.05.037 · Cited by 2,435
Kigerl, K. A., Gensel, J. C., Ankeny, D. P., Alexander, J. K., Donnelly, D. J., & Popovich, P. G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3257-09.2009 · Cited by 2,130
Identification of RIP1 kinase as a specific cellular target of necrostatins
Degterev, A., Hitomi, J., Germscheid, M., Ch'en, I. L., Korkina, O., Teng, X., Abbott, D., Cuny, G. D., Yuan, C., Wagner, G., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.83 · Cited by 2,059
Self-citation
Cited by
Sorted by citations
Items 201–300 of 993
Mechanisms and repair strategies for white matter degeneration in CNS injury and diseases
Shahsavani, N., Kataria, H., & Karimi‐Abdolrezaee, S. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166117 · Cited by 43
The Emerging Role of Ferroptosis in Sepsis
Liu, Y., Tan, S., Wu, Y., & Tan, S. (2022) · DNA and Cell Biology · doi:10.1089/dna.2021.1072 · Cited by 47
Wu, L., Wang, X. J., Luo, X., Zhang, J., Zhao, X., & Qiu, C. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1427679 · Cited by 49
Telegina, D. V., Suvorov, G. K., Kozhevnikova, O. S., & Kolosova, N. G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225632 · Cited by 42
Inhibition of gingival fibroblast necroptosis mediated by RIPK3/MLKL attenuates periodontitis
Zhang, K., Chen, X. L., Zhou, R., Chen, Z., Wu, B., Qiu, W., & Fang, F. (2023) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13841 · Cited by 41
Dai, W., Zheng, P., Wu, J. H., Chen, S., Deng, M., Tong, X., Liu, F., Shang, X., & Qian, K. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1247131 · Cited by 41
Jin, Z., Dong, J., Wang, Y., & Liu, Y. (2023) · European journal of medical research · doi:10.1186/s40001-023-01439-2 · Cited by 40
RIPK1 inhibitors: A key to unlocking the potential of necroptosis in drug development
Bai, Y., Qiao, Y., Li, M., Yang, W., Chen, H., Wu, Y., & Zhang, H. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116123 · Cited by 42
Meng, Q., Wei, K., & Shan, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1433898 · Cited by 44
Yu, W., He, J., Cai, X., Yu, Z., Zou, Z., & Fan, D. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.890958 · Cited by 41
Sun, S., Huan, S., Li, Z., Yao, Y., Su, Y., Xia, S., Wang, S., Xu, X., Shao, J., Zhang, Z., et al. (2022) · PeerJ · doi:10.7717/peerj.13376 · Cited by 40
Necroptosis protects against exacerbation of acute pancreatitis
Boonchan, M., Arimochi, H., Otsuka, K., Kobayashi, T., Uehara, H., Jaroonwitchawan, T., Sasaki, Y., Tsukumo, S., & Yasutomo, K. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03847-w · Cited by 40
Xu, Y. M., Hu, X., Li, F., Zhang, H., Lou, J., Wang, X., Wang, H., Yin, L., Ni, W., Kong, J., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8186877 · Cited by 40
Zhao, W., Fan, C.-L., Hu, X., Ban, X.-X., Wan, H., He, Y., Zhāng, Q., & Xiong, K. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01373-1 · Cited by 44
Bravo, G. M., Class, C. A., Gañán‐Gómez, I., Kanagal‐Shamanna, R., Sasaki, K., Richard‐Carpentier, G., Naqvi, K., Wei, Y., Yang, H., Soltysiak, K. A., et al. (2019) · Leukemia · doi:10.1038/s41375-019-0623-5 · Cited by 39
Chen, Y., Hong, T., Chen, F., Sun, Y., Wang, Y., & Cui, L. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.631827 · Cited by 40
Progranulin in neurodegenerative dementia
Wang, X., Zeng, P. H., Fang, Y., Zhang, T., & Tian, Q. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15378 · Cited by 39
Understanding Necroptosis in Pancreatic Diseases
He, R., Wang, Z., Dong, S., Chen, Z., & Zhou, W. (2022) · Biomolecules · doi:10.3390/biom12060828 · Cited by 38
Calderón‐Garcidueñas, L., Torres‐Jardón, R., Franco-Lira, M., Kulesza, R. J., González-Maciel, A., Reynoso-Robles, R., Brito-Aguilar, R., García-Arreola, B., Revueltas-Ficachi, P., Barrera-Velázquez, J. A., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200891 · Cited by 40
Discovery of bardoxolone derivatives as novel orally active necroptosis inhibitors
Wang, Y., Ma, H., Huang, J., Yao, Z., Yu, J., Zhang, W., Zhang, L., Wang, Z., & Zhuang, C. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.113030 · Cited by 38
How to Use the Cuprizone Model to Study De- and Remyelination
Kipp, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031445 · Cited by 37
“Several other cell death mechanisms have been discovered and described in recent years: necroptosis [38,39], regulated by receptor-interacting protein kinases (RIPK1 and RIPK3); caspase-1-driven pyroptosis [40]; autophagy, a survival mechanism wherein cells degrade their components in response to…”
BackgroundMechanism of cell death pathways in status epilepticus and related therapeutic agents
Du, K., He, M., Zhao, D., Wang, Y., Ma, C., Liang, H., Wang, W., Min, D., Xue, L., & Guo, F. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112875 · Cited by 37
Sun, Y., Xu, L., Shao, H., Quan, D., Mo, Z., Wang, J., Zhang, W., Yu, J., Zhuang, C., & Xu, K. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01478 · Cited by 38
Bhaskaran, S., Kumar, G., Thadathil, N., Piekarz, K. M., Mohammed, S., Domínguez-López, S., Qaisar, R., Walton, D. A., Brown, J. L., Murphy, A., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102550 · Cited by 36
The Redox Protein High-Mobility Group Box 1 in Cell Death and Cancer
Chen, R., Zou, J., Kang, R., & Tang, D. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0236 · Cited by 39
Immunological mechanisms in steatotic liver diseases: An overview and clinical perspectives
Yan, M., Man, S., Ma, L., Guo, L., Huang, L., & Gao, W. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0315 · Cited by 39
Liu, J., Hu, H., & Wu, B. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147310 · Cited by 37
Ke, Q., Mu, Y., Hu, Y., Li, J., & Liu, J. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1611055 · Cited by 43
Yu, Y., Thonn, V., Patankar, J. V., Thoma, O., Waldner, M. J., Zielińska, M., Bao, L., González-Acera, M., Wallmüller, S., Engel, F. B., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-021-04483-0 · Cited by 36
Rothan, H. A., Kumari, P., Stone, S., Natekar, J. P., Arora, K., Auroni, T. T., & Kumar, M. (2022) · Pathogens · doi:10.3390/pathogens11020257 · Cited by 35
Rui, Y., Li, S., Luan, F., Li, D., Rong, L., & Zeng, N. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2427802 · Cited by 39
Al-Khayri, J. M., Ravindran, M., Banadka, A., Devaiah, V. C., Priya, K., Nagella, P., & Kukkemane, K. (2024) · Pharmaceuticals · doi:10.3390/ph17101391 · Cited by 42
Wu, L., Chung, J. Y., Cao, T., Jin, G., Edmiston, W. J., Hickman, S. E., Levy, E. S., Whalen, J. A., Abrams, E. S. L., Degterev, A., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04333-z · Cited by 35
Necroptosis in Alzheimer’s disease: Potential therapeutic target
Richard, R., & Mousa, S. A. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113203 · Cited by 37
NLRP3 inflammasome activation after ischemic stroke
Han, P.-P., Han, Y., Shen, X.-Y., Gao, Z.-K., & Bi, X. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114578 · Cited by 35
RIPK1 in necroptosis and recent progress in related pharmaceutics
Yao, K., Shi, Z., Zhao, F., Tan, C., Zhang, Y., Fan, H., Wang, Y., Li, X., Kong, J., Wang, Q., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1480027 · Cited by 34
Cell-specific activation of RIPK1 and MLKL after intracerebral hemorrhage in mice
Lüle, S., Wu, L., Sarro-Schwartz, A., Edmiston, W. J., Izzy, S., Songtachalert, T., Ahn, S. H., Fernandes, N. D., Jin, G., Chung, J. Y., et al. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20973609 · Cited by 34
The Role of HSP90α in Methamphetamine/Hyperthermia-Induced Necroptosis in Rat Striatal Neurons
Liao, L., Lu, S., Yan, W., Wang, S., Guo, L., Yang, Y., Huang, K., Hu, X., Zhāng, Q., Yan, J., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.716394 · Cited by 34
Guo, X., Wu, Y., Jia, Q., Ma, H., Fan, Z., Wang, S., Du, L.-X., Peng, Y., Fang, Z., & Zhang, X. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14095 · Cited by 34
Yu, Q., Chen, Y., Zhao, Y., Huang, S., Xin, X., Jiang, L., Wang, H., Wu, W., Qu, L., Xiang, C., et al. (2023) · Kidney Diseases · doi:10.1159/000529995 · Cited by 33
Rafique, H., Hu, X., Ren, T., Dong, R., Aadil, R. M., Zou, L., Sharif, M. K., & Li, L. (2023) · Nutrients · doi:10.3390/nu16010117 · Cited by 33
The Role of Natural Compounds and their Nanocarriers in the Treatment of CNS Inflammation
Khadka, B., Lee, J., Park, D. H., Kim, K.-T., & Bae, J. (2020) · Biomolecules · doi:10.3390/biom10101401 · Cited by 34
The regulation of necroptosis by ubiquitylation
Chen, Y., Ren, W., Wang, Q., He, Y., Ma, D., & Cai, Z. (2022) · APOPTOSIS · doi:10.1007/s10495-022-01755-8 · Cited by 32
Serinc2 deficiency exacerbates sepsis-induced cardiomyopathy by enhancing necroptosis and apoptosis
Hu, S., Huang, M., Mao, S., Yang, M., Ju, H., Liu, Z., Cheng, M., & Wu, G. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115903 · Cited by 32
PARP5A and RNF146 phase separation restrains RIPK1-dependent necroptosis
Hou, S., Zhang, J., Jiang, X., Yang, Y., Shan, B., Zhang, M., Liu, C., Yuan, J., & Xu, D. (2024) · Molecular Cell · doi:10.1016/j.molcel.2023.12.041 · Cited by 35
Self-citationGong, Q., Ali, T., Hu, Y., Gao, R., Mou, S., Luo, Y., Yang, C., Li, A., Li, T., Hao, L., et al. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01796-3 · Cited by 32
DHA attenuates Aβ-induced necroptosis through the RIPK1/RIPK3 signaling pathway in THP-1 monocytes
Yuan, S., Li, H., Yang, C., Xie, W., Wang, Y., Zhang, J., cai, Z., Mao, Z., Xie, W., & Lü, T. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110102 · Cited by 34
Altered mitochondrial calcium handling and cell death by necroptosis: An emerging paradigm
Faizan, M. I., & Ahmad, T. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.12.004 · Cited by 31
A narrative review of the role of necroptosis in liver disease: a double-edged sword
Li, X., Dong, G., Xiong, H., & Diao, H. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-5162 · Cited by 31
Hu, T., Zhao, X., Zhao, Y., Cheng, J., Xiong, J., & Lu, C. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.842218 · Cited by 32
Wang, T., Yin, Y., Jiang, X., Ruan, Y., Xu, J., Hu, X., Li, T., Chu, L., & Li, L. (2023) · Scientific Reports · doi:10.1038/s41598-023-41101-9 · Cited by 34
Li, N., Lu, W., Tang, L., Zhu, L., Deng, W., Liu, H., Huang, C., Jin, J., Zeng, J., Chen, S., et al. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70568 · Cited by 32
Jung, S., Chung, Y., Lee, Y., Lee, Y., Cho, J. W., Shin, E., Kim, H., & Oh, Y. J. (2019) · Cell Death Discovery · doi:10.1038/s41420-019-0210-6 · Cited by 31
Zhao, X., Quan, J., Tan, Y., Liu, Y., Liao, C., Li, Z., Liao, W., Liu, J., Cao, Y., & Luo, X. (2020) · PubMed Central · doi:10.21203/rs.3.rs-54832/v1 · Cited by 32
Crosstalk between lncRNAs in the apoptotic pathway and therapeutic targets in cancer
Ebrahimi, N., Parkhideh, S., Samizade, S., Esfahani, A. N., Samsami, S., Yazdani, E., Adelian, S., Chaleshtori, S. R., Shahamiri, K., Ahmadi, A., et al. (2022) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2022.04.003 · Cited by 31
Wu, L., Chang, E., Zhao, H., & Ma, D. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02014-2 · Cited by 34
Microglia programmed cell death in neurodegenerative diseases and CNS injury
Cai, L., Fan, Q., Pang, R., Chen, C., Zhang, Y., Xie, H., Huang, J., Wang, Y., Li, P., Huang, D., et al. (2024) · APOPTOSIS · doi:10.1007/s10495-024-02041-5 · Cited by 32
Targeting Necroptosis as a Promising Therapy for Alzheimer’s Disease
Zhao, W., Liu, Y., Xu, L., He, Y., Cai, Z., Yu, J., Zhang, W., Xing, C., Zhuang, C., & Qu, Z. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00172 · Cited by 31
Necroptosis in CNS diseases: Focus on astrocytes
Mitroshina, Е. V., Saviuk, M. O., & Vedunova, M. V. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1016053 · Cited by 34
Adulthood systemic inflammation accelerates the trajectory of age-related cognitive decline
Barter, J., Kumar, A., Bean, L. A., Ciesla, M. R., & Foster, T. C. (2021) · Aging · doi:10.18632/aging.203588 · Cited by 29
Microglial Dysfunction in Neurodegenerative Diseases via RIPK1 and ROS
Wu, Q., & Zou, C. (2022) · Antioxidants · doi:10.3390/antiox11112201 · Cited by 30
Li, X., Tong, H., Xu, S., Zhou, G., Yang, T., Yin, S., Yang, S., Li, X., & Li, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111787 · Cited by 35
Wang, Z.-J., Han, W.-N., Chai, S.-F., Li, Y., Fu, C.-J., Wang, C.-F., Cai, H.-Y., Li, X., Wang, X., Hölscher, C., et al. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.11.022 · Cited by 32
Lanquist, A. P., Gupta, S., Al‐Afyouni, K. F., Al‐Afyouni, M. H., Kodanko, J. J., & Turró, C. (2021) · Chemical Science · doi:10.1039/d1sc03213e · Cited by 29
Necroptosis in Pulmonary Diseases: A New Therapeutic Target
Wang, L., Zhou, L., Zhou, Y., Liu, L., Jiang, W., Zhang, H., & Liu, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.737129 · Cited by 30
Lan, Y., Bai, P., Liu, Y., Afshar, S., Striar, R., Rattray, A., Meyer, T. N., Langan, A. G., Posner, A. M., Shen, S., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01477 · Cited by 29
Hu, Y., Feng, X., Chen, J., Wu, Y., & Shen, L. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.11049 · Cited by 30
Wang, Y., Wang, K., Yan, J., Zhou, Q., & Wang, X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213886 · Cited by 32
Naderi, S., Khodagholi, F., Pourbadie, H. G., Naderi, N., Rafiei, S., Janahmadi, M., Sayehmiri, F., & Motamedi, F. (2022) · NeuroToxicology · doi:10.1016/j.neuro.2022.11.003 · Cited by 29
Pore-Forming Proteins: From Pore Assembly to Structure by Quantitative Single-Molecule Imaging
Margheritis, E. G., Kappelhoff, S., & Cosentino, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054528 · Cited by 29
Crosstalk Between Cell Death and Spinal Cord Injury: Neurology and Therapy
Song, Q., Cui, Q., Sun, S., Wang, Y., Yin, Y., & Zhang, L. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04188-3 · Cited by 30
RIPK1 senses S-adenosylmethionine scarcity to drive cell death and inflammation
Chen, Z., Gu, X., Chen, H., Zhang, H., Liu, J., Yang, X., Cai, Y. A., Zhang, M., Yan, L., Yang, Y., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.05.014 · Cited by 30
A novel neurodegenerative spectrum disorder in patients with MLKL deficiency
Faergeman, S. L., Evans, H. G., Attfield, K. E., Desel, C., Kuttikkatte, S. B., Sommerlund, M., Jensen, L. T., Frøkiær, J., Friese, M. A., Matthews, P. M., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2494-0 · Cited by 28
Zhang, H., Li, X., Li, M., Li, F., Li, F., Wang, L., Zhang, Y., Zhang, Y., Luo, Y., Wang, H., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107650 · Cited by 27
Discovery of a cooperative mode of inhibiting RIPK1 kinase
Meng, H., Wu, G., Zhao, X., Wang, A., Li, D., Tong, Y., Jin, T., Cao, Y., Shan, B., Hu, S., et al. (2021) · Cell Discovery · doi:10.1038/s41421-021-00278-x · Cited by 28
Self-citationTubulin and Tubulin Posttranslational Modifications in Alzheimer’s Disease and Vascular Dementia
Santiago-Mujika, E., Luthi‐Carter, R., Giorgini, F., Kalaria, R. N., & Mukaetova-Ladinska, E. B. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.730107 · Cited by 26
Zhāng, Q., Wan, X.-X., Hu, X., Zhao, W., Ban, X.-X., Huang, Y., Yan, W., & Xiong, K. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.809656 · Cited by 28
Mushroom Polysaccharides as Potential Candidates for Alleviating Neurodegenerative Diseases
Jiang, X., Li, S., Feng, X., Li, L., Hao, J., Wang, D., & Wang, Q. (2022) · Nutrients · doi:10.3390/nu14224833 · Cited by 29
Gut microbiota, pathogenic proteins and neurodegenerative diseases
Wei, W., Wang, S., Xu, C., Zhou, X., Lian, X., He, L., & Li, K. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.959856 · Cited by 30
Friend or foe: role of pathological tau in neuronal death
Wu, M., Chen, Z., Jiang, M. H., Bao, B., Li, D., Yin, X., Wang, X., Liu, D., & Zhu, L. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02024-z · Cited by 28
Arrázola, M. S., Lira, M., Quiroz, G., Véliz‐Valverde, F., Iqbal, S., Eaton, S. L., Kline, R., Lamont, D. J., Huerta, H., Ureta, G., et al. (2023) · Aging Cell · doi:10.1111/acel.13814 · Cited by 32
Nasseri, B., Zareian, P., & Alizade, H. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106546 · Cited by 28
Hou, B., Liu, M., Chen, Y., Ni, W., Suo, X.-G., Xu, Y. G., He, Q., Meng, X., & Hao, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1041117 · Cited by 27
Dopaminergic neuronal death via necroptosis in Parkinson's disease: A review of the literature
Regoni, M., Valtorta, F., & Sassone, J. (2023) · European Journal of Neuroscience · doi:10.1111/ejn.16136 · Cited by 31
Induced Necroptosis and Its Role in Cancer Immunotherapy
Zhang, Z., Zhang, F., Xie, W., Niu, Y., Wang, H., Li, G., Zhao, L., Wang, X., & Xie, W. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910760 · Cited by 28
Cai, J., Hu, D., Sakya, J., Sun, T., Wang, D., Wang, L., Mao, X., & Su, Z. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03427-y · Cited by 27
Sun, S., Li, Z., Huan, S., Kai, J., Xia, S., Su, Y., Ji, S., Chen, A., Wang, S., Xu, X., et al. (2022) · Phytotherapy Research · doi:10.1002/ptr.7483 · Cited by 27
Zhang, L., Mao, L., & Wang, H. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03028-6 · Cited by 27
Chen, B., Wu, J., Hu, S. H., Liu, Q., Yang, H., & You, Y. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03844-1 · Cited by 27
How to Build a Fire: The Genetics of Autoinflammatory Diseases
Zhang, J., Lee, P. Y., Aksentijevich, I. A., & Zhou, Q. (2023) · Annual Review of Genetics · doi:10.1146/annurev-genet-030123-084224 · Cited by 28
Jia, M., Li, Y.-Q., Xu, K., Zhang, Y., Tan, S., Zhang, Q., Peng, J., & Luo, X. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173041 · Cited by 28
Mendelian diseases of dysregulated canonical NF-κB signaling: From immunodeficiency to inflammation
Schnappauf, O., & Aksentijevich, I. A. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.2mr0520-166r · Cited by 30
Retinal Ganglion Cell Death in Glaucoma: Advances and Caveats
Yang, Y., & Sun, X. (2022) · Current Eye Research · doi:10.1080/02713683.2022.2068182 · Cited by 28
Defective prelamin A processing promotes unconventional necroptosis driven by nuclear RIPK1
Yang, Y., Zhang, J., Lv, M., Cui, N., Shan, B., Sun, Q., Yan, L., Zhang, M., Zou, C., Yuan, J., et al. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01374-2 · Cited by 27
Self-citationZhang, Q., Li, Y., Liu, Y., Wang, X., Yang, Y., & Shi, L. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111195 · Cited by 29
Cai, B., Wang, Q., Zhong, L., Liu, F., Wang, X., & Chen, T. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s462333 · Cited by 26
Recent Advances in the Mechanisms of Postoperative Neurocognitive Dysfunction: A Narrative Review
Wang, T., Huang, X., Sun, S., Wang, Y., Han, L., Zhang, T., Zhang, T., & Chen, X. (2025) · Biomedicines · doi:10.3390/biomedicines13010115 · Cited by 27
Lee, S.-B., Youn, J., Jang, W., & Yang, H. O. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104491 · Cited by 25
Necroptosis and Neuroinflammation in Retinal Degeneration
Tao, Y., Murakami, Y., Vavvas, D. G., & Sonoda, K. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.911430 · Cited by 27
Fan, X., Xu, X., Wu, X., Xia, R., Gao, F., Zhang, Q., & Sun, W. (2022) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2022.07.001 · Cited by 26
Metadata
- Authors
- Yuan, J., Amin, P., & Ofengeim, D.
- Affiliations
- Harvard University (US)
- Sanofi (United States) (US)
- Corresponding author
- Yuan, Junying
- Venue
- Nature Reviews Neuroscience
- Published
- 2018-11-22
- Volume
- 20
- Issue
- 1
- Pages
- 19-33
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- PMC
- PMC6342007
- OpenAlex
- W2901410206
- Semantic Scholar
- a6626d511f6ce29e1ffd0f9740b5c693cadb4fb3
- Cited by
- 967
- References
- 179
- Citations by year
- 2026: 110 · 2025: 156 · 2024: 149 · 2023: 152 · 2022: 164 · 2021: 134 · 2020: 65 · 2019: 35
- FWCI
- 5.80
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Denali Therapeutics
- National Institutes of Health (4r01ns082257-04)
- National Institute on Aging (RF1AG055521, R01AG047231, R21AG059073)
- National Institute of Neurological Disorders and Stroke (R01-NS082257)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- necroptosis, RIPK1, neuroinflammation, RIPK3, MLKL, apoptosis, TNF-α, death receptor ligands, neurodegenerative diseases, multiple sclerosis, amyotrophic lateral sclerosis, Parkinson's disease, Alzheimer's disease, central nervous system disorders
- MeSH terms
- Necroptosis, Animals, Brain, Humans, Inflammation, Neurons, Phosphorylation, Neurodegenerative Diseases, Receptor-Interacting Protein Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review